CC - The Chemours Company
NYSE
->
Basic Materials
->
Specialty Chemicals
Wilmington,
United States
Type: Equity
CC price evolution
CC
| (in millions $) | 30 Oct 2024 | 30 Jun 2024 | 31 Mar 2024 | 31 Dec 2023 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $619 | $1353 | $1807 | |
| Short term investments | ||||
| Net receivables | $951 | $896 | $792 | $610 |
| Inventory | $1438 | $1368 | $1391 | $1352 |
| Total current assets | $3080 | $2937 | $3597 | $3835 |
| Long term investments | $169 | $165 | $158 | |
| Property, plant & equipment | $3427 | $3408 | $3461 | $3476 |
| Goodwill & intangible assets | $105 | $105 | $105 | |
| Total noncurrent assets | $4312 | $4381 | $4416 | |
| Total investments | $169 | $165 | $158 | |
| Total assets | $7463 | $7249 | $7978 | $8251 |
| Current liabilities | ||||
| Accounts payable | $1037 | $938 | $963 | $1159 |
| Deferred revenue | ||||
| Short long term debt | $37 | $41 | $51 | |
| Total current liabilities | $1777 | $1557 | $2231 | $2486 |
| Long term debt | $3988 | $4146 | $4166 | $4193 |
| Total noncurrent liabilities | $4967 | $4993 | $5026 | |
| Total debt | $4183 | $4207 | $4244 | |
| Total liabilities | $6806 | $6524 | $7224 | $7512 |
| Shareholders' equity | ||||
| Retained earnings | $1763 | $1828 | $1797 | $1782 |
| Other shareholder equity | -$353 | -$347 | -$274 | -$274 |
| Total shareholder equity | $723 | $752 | $737 | |
| (in millions $) | 31 Dec 2023 | 31 Jan 2023 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $1807 | $1304 | $1551 | $1105 |
| Short term investments | ||||
| Net receivables | $610 | $626 | $720 | $511 |
| Inventory | $1352 | $1404 | $1099 | $939 |
| Total current assets | $3835 | $3214 | $3345 | $2633 |
| Long term investments | $158 | $175 | $169 | $167 |
| Property, plant & equipment | $3476 | $3411 | $3381 | $3710 |
| Goodwill & intangible assets | $105 | $115 | $108 | $167 |
| Total noncurrent assets | $4416 | $4426 | $4205 | $4449 |
| Total investments | $158 | $175 | $169 | $167 |
| Total assets | $8251 | $7640 | $7550 | $7082 |
| Current liabilities | ||||
| Accounts payable | $1159 | $1228 | $1162 | $844 |
| Deferred revenue | ||||
| Short long term debt | $51 | $25 | $25 | $21 |
| Total current liabilities | $2486 | $1891 | $1858 | $1442 |
| Long term debt | $4193 | $3590 | $3903 | $4199 |
| Total noncurrent liabilities | $5026 | $4642 | $4610 | $4825 |
| Total debt | $4244 | $3813 | $3928 | $4220 |
| Total liabilities | $7512 | $6533 | $6468 | $6267 |
| Shareholders' equity | ||||
| Retained earnings | $1782 | $2170 | $1746 | $1303 |
| Other shareholder equity | -$274 | -$343 | -$364 | -$310 |
| Total shareholder equity | $737 | $1107 | $1081 | $813 |
| (in millions $) | 30 Oct 2024 | 30 Jun 2024 | 31 Mar 2024 | 31 Dec 2023 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $1501 | $1538 | $1350 | $1361 |
| Cost of revenue | $1232 | $1064 | $1114 | |
| Gross Profit | $286 | $306 | $286 | $247 |
| Operating activities | ||||
| Research & development | $26 | $28 | $26 | |
| Selling, general & administrative | $139 | $142 | $223 | |
| Total operating expenses | $164 | $168 | $174 | $263 |
| Operating income | $138 | $112 | -$16 | |
| Income from continuing operations | ||||
| EBIT | $148 | $130 | -$18 | |
| Income tax expense | -$3 | $12 | $15 | -$55 |
| Interest expense | -$58 | $66 | $63 | $63 |
| Net income | ||||
| Net income | -$27 | $70 | $52 | -$26 |
| Income (for common shares) | $70 | $52 | -$26 | |
| (in millions $) | 31 Dec 2023 | 31 Dec 2022 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $6027 | $6794 | $6345 | $4969 |
| Cost of revenue | $4721 | $5178 | $4964 | $3902 |
| Gross Profit | $1306 | $1616 | $1381 | $1067 |
| Operating activities | ||||
| Research & development | $108 | $118 | $107 | $93 |
| Selling, general & administrative | $1290 | $710 | $592 | $527 |
| Total operating expenses | $1551 | $844 | $705 | $700 |
| Operating income | -$245 | $772 | $676 | $367 |
| Income from continuing operations | ||||
| EBIT | -$111 | $904 | $861 | $389 |
| Income tax expense | -$81 | $163 | $68 | -$40 |
| Interest expense | $208 | $163 | $185 | $210 |
| Net income | ||||
| Net income | -$238 | $578 | $608 | $219 |
| Income (for common shares) | -$238 | $578 | $608 | $219 |
| (in millions $) | 30 Oct 2024 | 30 Jun 2024 | 31 Mar 2024 | 31 Dec 2023 |
|---|---|---|---|---|
| Net income | $70 | $52 | -$26 | |
| Operating activities | ||||
| Depreciation | $74 | $71 | $74 | |
| Business acquisitions & disposals | $3 | $5 | ||
| Stock-based compensation | $6 | $1 | $5 | |
| Total cash flows from operations | -$620 | -$290 | $484 | |
| Investing activities | ||||
| Capital expenditures | -$73 | -$102 | -$135 | |
| Investments | $1 | -$2 | ||
| Total cash flows from investing | -$246 | -$70 | -$101 | -$130 |
| Financing activities | ||||
| Dividends paid | -$112 | -$37 | -$37 | -$37 |
| Sale and purchase of stock | $7 | $1 | $1 | |
| Net borrowings | -$9 | -$16 | $26 | |
| Total cash flows from financing | -$121 | -$40 | -$54 | -$7 |
| Effect of exchange rate | -$3 | -$4 | -$9 | $13 |
| Change in cash and equivalents | -$1141 | -$734 | -$454 | $360 |
| (in millions $) | 31 Dec 2023 | 31 Dec 2022 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Net income | -$238 | $578 | $608 | $219 |
| Operating activities | ||||
| Depreciation | $307 | $291 | $317 | $320 |
| Business acquisitions & disposals | $143 | $33 | $508 | $5 |
| Stock-based compensation | $18 | $27 | $34 | $16 |
| Total cash flows from operations | $556 | $754 | $820 | $807 |
| Investing activities | ||||
| Capital expenditures | -$370 | -$307 | -$277 | -$267 |
| Investments | -$8 | $3 | -$12 | $27 |
| Total cash flows from investing | -$229 | -$284 | $220 | -$234 |
| Financing activities | ||||
| Dividends paid | -$149 | -$154 | -$164 | -$164 |
| Sale and purchase of stock | -$50 | -$444 | -$150 | $16 |
| Net borrowings | $389 | -$80 | -$243 | -$285 |
| Total cash flows from financing | $172 | -$685 | -$560 | -$449 |
| Effect of exchange rate | $4 | -$32 | -$34 | $38 |
| Change in cash and equivalents | $503 | -$247 | $446 | $162 |
News
Fundamentals
| Market cap | $2.65B |
|---|---|
| Enterprise value | N/A |
| Shares outstanding | 149.39M |
| Revenue | $5.75B |
|---|---|
| EBITDA | N/A |
| EBIT | N/A |
| Net Income | $69.00M |
| Revenue Q/Q | 0.94% |
| Revenue Y/Y | -4.23% |
| P/E ratio | 38.37 |
|---|---|
| EV/Sales | N/A |
| EV/EBITDA | N/A |
| EV/EBIT | N/A |
| P/S ratio | 0.46 |
| P/B ratio | N/A |
| Book/Share | N/A |
| Cash/Share | N/A |
| EPS | $0.46 |
|---|---|
| ROA | 0.89% |
| ROE | N/A |
| Debt/Equity | 10.19 |
|---|---|
| Net debt/EBITDA | N/A |
| Current ratio | 1.73 |
| Quick ratio | 0.92 |